Centene Medicare Advantage Fundamentals Outpace HBR Deficit Offset — Company Talk

What happened

Centene's health benefits ratio stayed at 92.7% in the third quarter of 2026, the same as a year earlier. The company credits Medicare Advantage and Prescription Drug Plan performance, plus improved Marketplace pricing, and no longer needs a Medicare Advantage premium deficiency reserve.

Confirmed

Global impact / market context

The health benefits ratio is the share of premiums paid out for medical care, so a steady ratio while guidance improves suggests costs are under better control. Removing the reserve, money set aside for expected Medicare Advantage losses, points to that segment nearing profitability.

Analyst inference

Centene's lowered full-year guidance midpoint of 90.75% signals management expects lower medical costs relative to premiums, which can support profit per sale and cash available. Investors may compare this trajectory with peers facing Medicare Advantage cost pressure.

Analyst inference

What to watch

1. Centene lowered its full-year health benefits ratio guidance to 90.4% to 91.1%, with the midpoint improving by 15 basis points to 90.75%, which means the expected share of premiums spent on care fell. Confirmed
2. Watch whether Medicare Advantage moves fully into profitability, since the company no longer requires a premium deficiency reserve, a cushion for expected losses in that segment. Proposed
3. Track Marketplace member acuity and pricing, because improved risk transfer there supports revenue and profit per sale, while medical cost trends could reverse the guidance improvement. Analyst inference

Evidence

• Original source link unavailable